ストックスクリーナーアプリを入手
18.90
1.20%
-0.23
アフターアワーズ：
18.86
-0.04
-0.21%
前日終値:
$19.13
開ける：
$18.9
24時間の取引高:
14.41M
Relative Volume:
0.74
時価総額：
$36.29B
収益：
$15.29B
当期純損益:
$1.62B
株価収益率:
22.41
EPS:
0.8433
ネットキャッシュフロー:
$1.82B
1週間 パフォーマンス:
-0.63%
1か月 パフォーマンス:
+2.66%
6か月 パフォーマンス:
+6.18%
1年 パフォーマンス:
-16.15%
1日の値動き範囲:
$18.77
$18.94
1週間の範囲:
$18.77
$19.36
52週間の値動き範囲:
$14.02
$22.87
Kenvue Inc Stock (KVUE) Company Profile
名前
Kenvue Inc
電話
908-874-1200
住所
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, KMB
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
18.90 | 36.73B | 15.29B | 1.62B | 1.82B | 0.8433 |
PG
Procter Gamble Co
|
146.97 | 347.26B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
60.21 | 133.13B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
90.08 | 73.32B | 20.80B | 2.22B | 3.77B | 2.5772 |
KMB
Kimberly Clark Corp
|
107.31 | 36.14B | 16.56B | 1.75B | 1.84B | 6.36 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-30 | ダウングレード | Jefferies | Buy → Hold |
| 2025-10-29 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2025-09-26 | アップグレード | Rothschild & Co Redburn | Neutral → Buy |
| 2025-04-10 | 開始されました | Redburn Atlantic | Neutral |
| 2025-03-24 | 開始されました | Evercore ISI | In-line |
| 2025-01-06 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2024-09-24 | 開始されました | Jefferies | Buy |
| 2024-09-24 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | 再開されました | Citigroup | Neutral |
| 2024-04-11 | 開始されました | Bernstein | Underperform |
| 2024-04-03 | 開始されました | William Blair | Mkt Perform |
| 2024-03-01 | 再開されました | Goldman | Neutral |
| 2023-11-17 | 開始されました | Piper Sandler | Neutral |
| 2023-09-11 | アップグレード | Deutsche Bank | Hold → Buy |
| 2023-09-07 | 開始されました | Canaccord Genuity | Buy |
| 2023-09-06 | 開始されました | Argus | Hold |
| 2023-08-24 | アップグレード | Goldman | Neutral → Buy |
| 2023-07-25 | 開始されました | Edward Jones | Buy |
| 2023-06-01 | 開始されました | HSBC Securities | Hold |
| 2023-05-30 | 開始されました | BofA Securities | Buy |
| 2023-05-30 | 開始されました | Citigroup | Neutral |
| 2023-05-30 | 開始されました | Deutsche Bank | Hold |
| 2023-05-30 | 開始されました | Exane BNP Paribas | Neutral |
| 2023-05-30 | 開始されました | Goldman | Neutral |
| 2023-05-30 | 開始されました | JP Morgan | Overweight |
| 2023-05-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-05-30 | 開始されました | UBS | Neutral |
すべてを表示
Kenvue Inc (KVUE) 最新ニュース
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 - The Joplin Globe
Levin Capital Strategies L.P. Raises Stake in Kenvue Inc. $KVUE - MarketBeat
Technical Reactions to KVUE Trends in Macro Strategies - Stock Traders Daily
Kenvue Inc. (NYSE:KVUE) Given Average Rating of "Hold" by Analysts - MarketBeat
Kenvue broadens China focus on minor ailment management - China Daily Global Edition
What to expect from Kenvue’s Q2 2026 earnings report - MSN
KBC Group NV Increases Holdings in Kenvue Inc. $KVUE - MarketBeat
SEB Asset Management AB Purchases New Position in Kenvue Inc. $KVUE - MarketBeat
Dimensional Fund Advisors LP Has $383.94 Million Position in Kenvue Inc. $KVUE - MarketBeat
The Listerine Cool Mint MouthwashKenvue bets on bold flavor and plaque control - Ad-hoc-news.de
Kenvue stock steadies as consumer health margins lift earnings outlook - Ad-hoc-news.de
Listerine Cool Mint by Kenvuemouthwash mainstay keeps mint segment humming - Ad-hoc-news.de
Barclays Adjusts Price Target on Kenvue to $19 From $18, Maintains Equalweight Rating - marketscreener.com
What to Expect From Kenvue’s Q2 2026 Earnings Report - Inkl
Kenvue Inc. $KVUE Shares Sold by Kapitalo Investimentos Ltda - MarketBeat
Swiss National Bank Has $96.94 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock trades steadily as consumer health spin-off builds earnings record - Ad-hoc-news.de
Kenvue Inc. (KVUE) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Kenvue Inc. $KVUE Stake Lifted by Hsbc Holdings PLC - MarketBeat
California Public Employees Retirement System Decreases Stake in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock holds steady as the latest report frames 2026 margins - Ad-hoc-news.de
Is It Too Late to Buy Johnson & Johnson After Its Blowout Earnings Report? - The Motley Fool
Bank of New York Mellon Corp Sells 223,497 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue stock trades steadily as consumer health margins hold after spin-off - ad-hoc-news.de
Listerine Cool Mint by Kenvue Inc.mouthwash classic fuels recurring sales - ad-hoc-news.de
Illinois Municipal Retirement Fund Buys 72,348 Shares of Kenvue Inc. $KVUE - MarketBeat
How Affirmed Talc Successor Liability At Kenvue (KVUE) Has Changed Its Investment Story - simplywall.st
Kenvue stock trades steadily as consumer health margins stay in focus - ad-hoc-news.de
Kenvue Inc. stock rises Thursday, outperforms market - MarketWatch
KVUE Maintained by UBS -- Price Target Raised to $20.00 - GuruFocus
Diversify Wealth Management LLC Buys New Stake in Kenvue Inc. $KVUE - MarketBeat
Blackhawk Capital Partners LLC Invests $1.66 Million in Kenvue Inc. $KVUE - MarketBeat
Daily Brief Consumer: Colowide Co Ltd, Seven & I Holdings, Alibaba, New Hope Dairy Co Ltd, Global Education Communities C, Kenvue , Netflix Inc, Shadowfax Technologies, Suminoe Textile, Tailored Brands and more - Smartkarma
Neutrogena® announces 'Break the Rules' to break beauty's rules with scienceA new view of care - Kenvue
Kenvue stock holds steady as investors wait for the next catalyst - ad-hoc-news.de
Fifth Third Bancorp Grows Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock falls Tuesday, underperforms market - MarketWatch
Filippo Falorni Reiterates Hold on Kenvue, Keeps Price Target Unchanged at $19 Amid Renewed Tylenol Litigation Risks - TipRanks
US appeals court revives hundreds of private lawsuits linking Tylenol to autism - Reuters
Update: Kenvue Must Face Claims Linking Tylenol to Autism, Appeals Court Says - Moomoo
Calamos Advisors LLC Acquires 651,000 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue/Kimberly-Clark Deal Not in Jeopardy Despite Tylenol Ruling -- Market Talk - Moomoo
Second Circuit Court of Appeals Ruling - Kenvue
Kenvue Inc. stock falls Monday, underperforms market - MarketWatch
Kenvue's Tylenol Liability Nightmare: Appeals Court Reversal Ignites Fresh Legal Battle - Kavout | AI
U.S. appeals court revives more than 500 lawsuits against Tylenol-maker Kenvue over autism claims - The Globe and Mail
KVUE Stock Dips After Court Revives Tylenol Autism Lawsuits - Stocktwits
Kenvue faces revived Tylenol autism lawsuits after U.S. appeals court ruling - Traders Union
Tylenol-Maker Kenvue Must Face Autism Claims, Appeals Court Says - Bloomberg.com
Tylenol-Maker Kenvue Must Face Autism Lawsuits, Court Says (2) - Bloomberg Law News
Kenvue options trading climbs to over 16,000 contracts By Investing.com - Investing.com Nigeria
Kenvue Inc (KVUE) 財務データ
収益
当期純利益
現金流量
EPS
1.44%
大文字化:
|
ボリューム (24 時間):